BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 18615122)

  • 1. Restorative interventions for HIV facial lipoatrophy.
    Carey D; Liew S; Emery S
    AIDS Rev; 2008; 10(2):116-24. PubMed ID: 18615122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction of facial lipoatrophy using autologous fat transplants in HIV-infected adolescents.
    Dollfus C; Blanche S; Trocme N; Funck-Brentano I; Bonnet F; Levan P
    HIV Med; 2009 May; 10(5):263-8. PubMed ID: 19178590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary surgical management of HIV-associated facial lipoatrophy.
    Funk E; Bressler FJ; Brissett AE
    Otolaryngol Head Neck Surg; 2006 Jun; 134(6):1015-22. PubMed ID: 16730549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of facial lipoatrophy in HIV-infected patients.
    Prescrire Int; 2008 Aug; 17(96):170. PubMed ID: 19492497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of lipoatrophy and aging: volume deficits in the face.
    Coleman S; Saboeiro A; Sengelmann R
    Aesthetic Plast Surg; 2009 Jan; 33(1):14-21. PubMed ID: 18987910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical correction of HIV-associated facial lipoatrophy.
    Guaraldi G; Fontdevila J; Christensen LH; Orlando G; Stentarelli C; Carli F; Zona S; de Santis G; Pedone A; De Fazio D; Bonucci P; Martínez E
    AIDS; 2011 Jan; 25(1):1-12. PubMed ID: 20975513
    [No Abstract]   [Full Text] [Related]  

  • 7. Management options for facial lipoatrophy.
    Cofrancesco J; Brown T; Martins CR
    AIDS Read; 2004 Dec; 14(12):639-40, 645-50. PubMed ID: 15619779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-associated facial lipoatrophy--review of current therapy options.
    Bechara FG; Sand M; Potthoff A; Altmeyer P; Brockmeyer NH;
    Eur J Med Res; 2008 Mar; 13(3):93-9. PubMed ID: 18499554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effect of polyalkylimide gel injections on severity of facial lipoatrophy and quality of life of HIV-positive patients.
    Karim RB; de Lint CA; van Galen SR; van Rozelaar L; Nieuwkerk PT; Askarizadeh E; Hage JJ
    Aesthetic Plast Surg; 2008 Nov; 32(6):873-8. PubMed ID: 18551339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost consequences of HIV-associated lipoatrophy.
    Hornberger J; Rajagopalan R; Shewade A; Loutfy MR
    AIDS Care; 2009 May; 21(5):664-71. PubMed ID: 19444676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of HIV facial lipoatrophy with a submalar porous polyethylene implant (Medpor)].
    Claude O; Domergue Than Trong E; Blanc R; Ascher B; Bagot M; Meningaud JP; Lantieri L
    Ann Chir Plast Esthet; 2009 Feb; 54(1):21-8. PubMed ID: 19042066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of facial lipoatrophy via autologous fat transfer.
    Cohen G; Treherne A
    J Drugs Dermatol; 2009 May; 8(5):486-9. PubMed ID: 19537373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipodystrophy and quality of life of HIV-infected persons.
    Guaraldi G; Murri R; Orlando G; Squillace N; Stentarelli C; Zona S; Garlassi E; Martínez E
    AIDS Rev; 2008; 10(3):152-61. PubMed ID: 18820717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polylactic acid injections: usefullness for the treatment of facial lipoatrophy in HIV+ patients under tritherapy].
    Piquet M; Brignol L; Chatelain B; Rey D; Ricbourg B; Meyer C
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):496-504. PubMed ID: 17675198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between lipoatrophy and quality of life.
    Echavez M; Horstman W
    AIDS Read; 2005 Jul; 15(7):369-75. PubMed ID: 16044579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches to treatment of HIV facial lipoatrophy.
    Jones D
    Skin Therapy Lett; 2005 Nov; 10(9):5-7. PubMed ID: 16292459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facial lipohypertrophy in HIV-infected subjects who underwent autologous fat tissue transplantation.
    Guaraldi G; De Fazio D; Orlando G; Murri R; Wu A; Guaraldi P; Esposito R
    Clin Infect Dis; 2005 Jan; 40(2):e13-5. PubMed ID: 15655734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A ribose-crosslinked collagen filler treatment for facial lipoatrophy associated with the treatment of human immunodeficiency virus.
    Reytan N; Rzany B
    J Drugs Dermatol; 2008 Dec; 7(12):1169-71. PubMed ID: 19137772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porcine filler for facial lipoatrophy associated with human immunodeficiency virus treatment.
    Reytan N; Rzany B
    J Drugs Dermatol; 2008 Sep; 7(9):884-6. PubMed ID: 19112805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bridging a gap: surgical management of HIV-associated lipoatrophy.
    Moyle GJ
    AIDS Read; 2004 Sep; 14(9):472-5. PubMed ID: 15457598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.